Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Back to dashboard
Company Information
About this company
Key people
Jon Sigurdsson
Chairman of the Board
Nicklas Hansen
Director
Henrik Blomquist
Independent Director
Pia Marions
Independent Director
Bronwyn Brophy O'Connor
President, Chief Executive Officer
Paer Ihrskog
Chief Financial Officer
Ermanno Sironi
Chief Operating Officer
Jessica Jonasson
Chief Human Resources Officer
Erin Schardt
Senior Vice President, General Manager, Americas
Olivia Natens
Senior Vice President - Sales and Marketing
Rickard Ericsson
Senior Vice President - Innovation
David T. Hansen
Director
Click to see more
Key facts
- Shares in issue135.45m
- EPICVITR
- ISINSE0011205202
- LocationSweden
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capSEK 13.25bn
- Employees1,103
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.